Skip to main content
. 2019 Dec 6;12(2):126–133. doi: 10.3892/mco.2019.1961

Table I.

Patient characteristics.

Characteristic 5-days-on/2-days-off (n=21) Conventional (n=21) P-value
Age (years) 67 (38-80) 68 (46-75) 0.9354
Sex     0.0614
     Male 6 (28.6) 12 (57.1)  
     Female 15 (71.4) 9 (42.9)  
PS     1.0000
     0 21(100) 21(100)  
     1 0 (0) 0 (0)  
Lymph node dissection     0.2931
     D0 0 (0) 0 (0)  
     D1 0 (0) 0 (0)  
     D2 2 (9.5) 1 (54.8)  
     D3 19 (90.5) 20 (95.2)  
Location of cancer     0.9588
     C 1 (4.8) 2 (9.5)  
     A 4 (19.0) 4 (19.0)  
     T 2 (9.5) 3 (14.3)  
     D 1 (4.8) 1 (4.8)  
     S 8 (38.1) 6 (28.6)  
     RS 2 (9.5) 2 (9.5)  
     Ra 3 (14.3) 2 (9.5)  
     Rb 0 (0) 1 (4.8)  
Stagea     0.0397
     IIA 5 (23.8) 0 (0)  
     IIB 1 (4.8) 0 (0)  
     IIIA 3 (14.3) 9 (42.9)  
     IIIB 12 (57.1) 11 (52.4)  
     IIIC 0 (0) 1 (4.8)  
Tumor depth of invasion     0.0727
     T1 2 (9.5) 4 (19.0)  
     T2 1 (4.8) 5 (23.8)  
     T3 17 (81.0) 8 (38.1)  
     T4 1 (4.8) 4 (19.0)  
Lymphatic invasion     0.6200
     Ly0 11 (52.4) 10 (47.6)  
     Ly1 6 (28.6) 6 (28.6)  
     Ly2 3 (14.3) 5 (23.8)  
     Ly3 1 (4.8) 0 (0)  
Venous invasion     0.1885
     V0 13 (64.9) 9 (42.9)  
     V1 6 (28.6) 7 (33.3)  
     V2 1 (4.8) 3 (14.3)  
     V3 1 (4.8) 0 (0.0)  
     Unknown 0 (0.0) 2 (9.5)  
Histological classification     0.4283
     Pap 1 (4.8) 0 (0.0)  
     Wel 7 (33.3) 10 (47.6)  
     Mod 13 (61.9) 11 (52.4)  

aTNM classification. Tumor depth of invasion was defined as follows: T1, tumor invades submucosa; T2, tumor invades muscularis propria; T3, tumor invades through the muscularis propria into pericolorectal tissues; T4, tumor penetrates to the surface of the visceral peritoneum or tumor directly invades or is adherent to other organs or structures. Values are expressed as the median (range) or n (%). PS, performance status; C, cecum; A, ascending colon; T, transverse colon; D, descending colon; S, sigmoid colon; Ra, upper rectum; Rb, lower rectum; Pap, papillary adenocarcinoma; Wel, well-differentiated adenocarcinoma; Mod, moderately differentiated adenocarcinoma.